Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases (2006)
- Autores:
- Autores USP: ANDRADE, JURANDYR MOREIRA DE - FMRP ; SILVA, ALFREDO RIBEIRO DA - FMRP
- Unidade: FMRP
- Assuntos: MAMA; NEOPLASIAS; PATOLOGIA CLÍNICA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Polish Journal of Pathology
- ISSN: 1233-9687
- Volume/Número/Paginação/Ano: v. 57, n. 3, p. 161-165, 2006
-
ABNT
RIBEIRO-SILVA, Alfredo et al. Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases. Polish Journal of Pathology, v. 57, n. 3, p. 161-165, 2006Tradução . . Acesso em: 19 abr. 2024. -
APA
Ribeiro-Silva, A., Mendes, C. F., Costa, I. S., Moura, H. B. de, Tiezzi, D. G., & Andrade, J. M. de. (2006). Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases. Polish Journal of Pathology, 57( 3), 161-165. -
NLM
Ribeiro-Silva A, Mendes CF, Costa IS, Moura HB de, Tiezzi DG, Andrade JM de. Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases. Polish Journal of Pathology. 2006 ; 57( 3): 161-165.[citado 2024 abr. 19 ] -
Vancouver
Ribeiro-Silva A, Mendes CF, Costa IS, Moura HB de, Tiezzi DG, Andrade JM de. Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases. Polish Journal of Pathology. 2006 ; 57( 3): 161-165.[citado 2024 abr. 19 ] - HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin
- HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases with review of the literature
- HER2 overexpression predicts survival in stage II and III of breast cancer patients treated with neoadjuvant docetaxel plus epirubicin
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases and review of the literature
- HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin
- Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer
- Apoptosis induced by neodjuvant chemotherapy in breast cancer
- Tumor infiltrating lymphocytes are related to lymph node metastasis in patients with T1-T2 breast cancer
- Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
